Advertisement
Singapore markets close in 3 hours 6 minutes
  • Straits Times Index

    3,301.78
    +29.06 (+0.89%)
     
  • Nikkei

    38,386.54
    +834.38 (+2.22%)
     
  • Hang Seng

    17,186.35
    +357.42 (+2.12%)
     
  • FTSE 100

    8,044.81
    +20.94 (+0.26%)
     
  • Bitcoin USD

    66,758.67
    +206.35 (+0.31%)
     
  • CMC Crypto 200

    1,437.53
    +22.77 (+1.61%)
     
  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     
  • Dow

    38,503.69
    +263.71 (+0.69%)
     
  • Nasdaq

    15,696.64
    +245.33 (+1.59%)
     
  • Gold

    2,341.60
    -0.50 (-0.02%)
     
  • Crude Oil

    83.50
    +0.14 (+0.17%)
     
  • 10-Yr Bond

    4.5980
    -4.6500 (-50.28%)
     
  • FTSE Bursa Malaysia

    1,568.59
    +6.95 (+0.45%)
     
  • Jakarta Composite Index

    7,168.54
    +57.73 (+0.81%)
     
  • PSE Index

    6,585.26
    +78.46 (+1.21%)
     

Why Teva Stock Trounced the Market on Friday

The stock of Teva Pharmaceutical Industries (NYSE: TEVA) closed out the trading week in style, popping by almost 6% on Friday. The generic-drug specialist was the subject of a recommendation upgrade from a noted financial institution, hence the share price rise. Analyst Jason Gerberry from the bank's securities unit raised his recommendation on Teva from neutral to buy.